MetricAid Announces Appointment of Board of Directors to Support Accelerated Growth and Global Expansion
The newly appointed Board comprises:
Paul Tsaparis, former Board Chair of York University, former CEO and President of Hewlett-Packard Canada and currently a board member of Teranet, Metrolinx and Indspire. Mr. Tsaparis is a recognized leader in Canadian technology and innovation with extensive board experience in both public and private sectors. His deep understanding of growth-stage companies is a tremendous asset to MetricAid's long-term success.
Eugene Roman, former Chief Technology Officer of Canadian Tire and OpenText, current Executive-in-Residence at the Schulich School of Business for AI and a renowned figure in enterprise digital transformation. Mr. Roman brings decades of experience in IT strategy, cybersecurity, and large-scale systems architecture.
Dr. Mark Schweitzer, internationally respected radiologist and current Special Associate for Public Health, is planning the New School of Public Health at Wayne State University. Dr. Schweitzer offers deep clinical insight and a global healthcare perspective that aligns with MetricAid's commitment to physician-centred scheduling. Dr. Schweitzer has published more than 400 peer-reviewed papers with more than 27000 citations.
Mark Fam, President & CEO of Oak Valley Health, one of Canada's leading healthcare institutions. With extensive leadership in hospital operations, Mr. Fam strengthens MetricAid's strategic alignment with public health systems and complex care environments.
Warren Urquhart, currently Governance Counsel for Toronto Hydro, is licensed to practice Law in Ontario and New York. Warren sits as a current member of the Publications Advisory Board of the International Association of Privacy Professionals, directing content and coverage of global privacy law and AI Governance developments. In addition, Warren is an executive of both the Canadian Bar Association and the Ontario Bar Association's Privacy and Access to Information Bar Executive.
"The calibre of leadership now guiding MetricAid is a testament to both our past performance and our future ambitions," said Lora Webb, CEO of MetricAid. "We are thrilled to welcome directors whose influence spans global healthcare, world-class technology, and high-growth operations. We are more prepared than ever to shape the future of physician scheduling." MetricAid's mission: Revolutionize Emergency Medicine Scheduling For more information or to request interviews, please contact:
About MetricAid
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Canadian Natural Resources Reports Strong Q2 2025 Results
Canadian Natural Resources ( (CNQ)) has released its Q2 earnings. Here is a breakdown of the information Canadian Natural Resources presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Canadian Natural Resources Limited is a prominent player in the oil and gas sector, known for its extensive operations in oil sands mining, upgrading, and conventional oil and gas production, primarily based in Canada with some international exposure. In its second quarter of 2025, Canadian Natural Resources reported robust financial performance, driven by strategic acquisitions and efficient operations. The company highlighted its successful completion of a planned turnaround at the Athabasca Oil Sands Project ahead of schedule, alongside strong production and upgrader utilization rates. Key financial metrics for the quarter included net earnings of approximately $2.5 billion and adjusted net earnings of $1.5 billion. The company achieved a total production volume of 1,420,358 BOE/d, marking a 10% increase from the previous year. Strategic acquisitions, such as the Palliser Block and Montney assets, are expected to bolster future production and synergies. The company's management remains optimistic about the second half of 2025, anticipating continued strong operating results. Canadian Natural Resources plans to update its annual production guidance and capital forecast following the closure of the AOSP swap, reflecting its commitment to delivering shareholder value through strategic growth and operational excellence.
Cision Canada
3 hours ago
- Cision Canada
Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology
BEIJING, Aug. 19, 2025 /CNW/ -- From August 15-17, the 31 st China International Medical Equipment Exhibition and Scientific Conference (China-Hospeq 2025) was held in Beijing. Vital Materials officially launched the VITA Genesis, China's fully proprietary Photon Counting CT (PCCT) scanner, marking the entry of global medical imaging technology into the "Quantum Flux" sensing era and empowering Chinese innovation in precision diagnostics and treatment. The Photon Counting Detectors (PCD), as the core technology of PCCT, differ significantly from traditional Energy Integrating Detectors (EID). Traditional CT scanners require X-ray photons to first be converted into visible light, then into electrical signals. In contrast, the PCCT detector employs semiconductor materials, where X-ray photons excite electrons, creating electron-hole pairs proportional to photon energy. Charge carriers from the pairs are separated by an electric field to generate electrical pulses. Application-Specific Integrated Circuits (ASIC) categorize these pulses by energy bins, enabling precise photon counting and energy resolution. This breakthrough provides crucial technical support for multi-energy spectral imaging, significantly enhancing the diagnostic value of medical imaging. Currently, the PCCT detectors primarily utilize three materials: Cadmium Zinc Telluride (CdZnTe or CZT), Cadmium Telluride (CdTe), and Deep Silicon. CZT is emerging as a breakthrough for next-generation medical imaging technology due to its outstanding detection capabilities. The core value of VITA Genesis lies not only in adopting a detector solution based on the CZT, but more importantly in pioneering the mastery of PCCT's full vertical integration technology. This includes ultra-high purity metals purification and compounding, single crystal growth and processing, component design and development, CT system integration, and imaging algorithm development, establishing a global paradigm in the field of PCCT.
Globe and Mail
3 hours ago
- Globe and Mail
Metro's third-quarter results fall short of estimates as Buy Canadian trend begins to lose some steam
Consumers are still seeking local products, but executives at one of Canada's biggest grocers say the buy Canadian movement is starting to lose some steam. 'It's decelerating somewhat,' Metro Inc. MRU-T chief executive Eric La Flèche told analysts during a third-quarter earnings conference call on Wednesday. 'Consumers are still buying more Canadian, so we're seeing more growth on Canadian product than non-Canadian product, but it has decelerated slightly.' Earlier this year, trade disputes with the United States helped kick off the trend of shoppers favouring Canadian-made products, which pushed many grocers to increase their local offerings and promote domestic and local products with signs on their shelves. Meanwhile, tariffs from the U.S. and Canada's own counter-tariffs have continued to lead some food producers to request price increases from grocers including Metro. Mr. La Flèche said tariffs have pushed prices higher for about 3,000 products. 'The introduced tariffs and counter tariffs are also a contributing factor to food inflation as we continue to receive price increase requests from our vendor partners,' he said. Loblaw earnings jump on strong sales, demand for discount grocery brands After the counter-tariffs were imposed in March, some suppliers waited a bit but the price increases eventually rolled in, he said. 'Teams continue to negotiate to minimize the impact on consumers, and for now, the effect remains manageable.' The grocer has also been on the lookout for suppliers in other countries to minimize costs, Mr. La Flèche said. Metro Inc. reported a third-quarter profit of $323-million, up from $296.2-million in the same quarter last year. The grocery and drugstore retailer said its profit amounted to $1.48 per diluted share for the 16-week period ended July 5, up from $1.31 per diluted share a year ago. Sales for the quarter totalled $6.87-billion, up from $6.65-billion in the same quarter last year. Food same-store sales were up 1.9 per cent, while pharmacy same-store sales were up 5.5 per cent, with a 6.2 per-cent increase in prescription drugs and a 4-per-cent increase in front-store sales, primarily driven by over-the-counter products, cosmetics, and health and beauty. During the call, Mr. La Flèche noted shoppers are continuing to try and keep a lid on their grocery bills. 'The search for value has been ongoing for over a couple of years now or more, so it's the same trends,' he said. 'People are searching for value. Promotional levels are high. Private label sales are high, so we're seeing pretty much the same picture on the consumer side.' On an adjusted basis, Metro says it earned $1.52 per diluted share in its latest quarter, up from an adjusted profit of $1.35 per diluted share in the same quarter last year. RBC analyst Irene Nattel said in a note the results were 'solid and consistent' with expectations. Metro's stock price however dropped seven per cent Wednesday to close at $98.58 on the Toronto Stock Exchange. Ms. Nattel said the decline likely reflects high expectations among shareholders, though she noted Metro's track record 'of delivering visible, predictable, consistent results that underpins valuation, and Q3 results continue that trend.' She said Metro's results, along with recent earnings from Loblaw Cos. Ltd., reinforce her investment thesis on the grocers, as 'cash-strapped consumers moderate food away from home, and focus on value in everyday household purchases.' Ms. Nattel said Metro's outlook shows the company is focusing on realizing efficiencies from its significant investments in modernizing its supply chain in recent years. Metro has invested nearly $1-billion in modernizing its supply chains in Quebec and Ontario.
